Source: The Patriot Light | AWK Network | VIEW ORIGINAL POST ==>
Sick customers who bought some cold and flu medications have been falsely assured their nasal congestion would be relieved, an Australian law firm alleges.
Lawyers at JGA Saddler have filed a class action on behalf of millions of customers, alleging they were misled by pharmaceutical giant Johnson & Johnson’s over-the-counter medications including Codral Day and Night, Sudafed PE, and Benadryl PE.
The class action concerns tablets containing phenylephrine, a substance the U.S. Food and Drug Administration (FDA) has declared ineffective as a nasal decongestant when taken in tablet form.
Johnson & Johnson replaced pseudoephedrine with phenylephrine when the former was taken off shelves over drug abuse concerns in 2006.
Brisbane ear, nose and throat specialist Jo-Lyn McKenzie said phenylephrine was not a decongestant.
“It’s unconscionable and deeply unethical for corporations to sell health-care products while knowing they don’t work,” Dr McKenzie said.
Related Stories
JGA Saddler director Rebecca Jancauskas said Johnson & Johnson must be held accountable.
“[It has] manufactured and marketed a medication that decades of evidence have shown doesn’t work as claimed, relying on…
